Nikki Cheng Department of Pathology University of Kansas Medical Center Biography Publications Institution JoVE Articles Nikki Cheng has not added a biography. If you are Nikki Cheng and would like to personalize this page please email our Author Liaison for assistance. Publications Loss of One Tgfbr2 Allele in Fibroblasts Promotes Metastasis in MMTV: Polyoma Middle T Transgenic and Transplant Mouse Models of Mammary Tumor Progression Clinical & Experimental Metastasis. Apr, 2011 | Pubmed ID: 21374085 Loss of Transforming Growth Factor-beta Signaling in Mammary Fibroblasts Enhances CCL2 Secretion to Promote Mammary Tumor Progression Through Macrophage-dependent and -independent Mechanisms Neoplasia (New York, N.Y.). May, 2010 | Pubmed ID: 20454514 Quantitative Analysis of the Secretome of TGF-beta Signaling-deficient Mammary Fibroblasts Proteomics. Jul, 2010 | Pubmed ID: 20405477 Chemokine Signaling in Cancer: Implications on the Tumor Microenvironment and Therapeutic Targeting Cancer Therapy. Apr, 2009 | Pubmed ID: 20651940 Abrogation of TGF-beta Signaling Enhances Chemokine Production and Correlates with Prognosis in Human Breast Cancer The Journal of Clinical Investigation. Jun, 2009 | Pubmed ID: 19451693 Transforming Growth Factor-beta Signaling-deficient Fibroblasts Enhance Hepatocyte Growth Factor Signaling in Mammary Carcinoma Cells to Promote Scattering and Invasion Molecular Cancer Research : MCR. Oct, 2008 | Pubmed ID: 18922968 Identification of Novel Smad2 and Smad3 Associated Proteins in Response to TGF-beta1 Journal of Cellular Biochemistry. Oct, 2008 | Pubmed ID: 18729074 Epidermal Growth Factor Receptor Plays a Significant Role in Hepatocyte Growth Factor Mediated Biological Responses in Mammary Epithelial Cells Cancer Biology & Therapy. Apr, 2007 | Pubmed ID: 17495520 Enhanced Hepatocyte Growth Factor Signaling by Type II Transforming Growth Factor-beta Receptor Knockout Fibroblasts Promotes Mammary Tumorigenesis Cancer Research. May, 2007 | Pubmed ID: 17495323 Inhibition of Retinal Neovascularization by Soluble EphA2 Receptor Experimental Eye Research. Apr, 2006 | Pubmed ID: 16359662 Genomic and Proteomic Analysis of Mammary Tumors Arising in Transgenic Mice Journal of Proteome Research. Nov-Dec, 2005 | Pubmed ID: 16335954 Loss of TGF-beta Type II Receptor in Fibroblasts Promotes Mammary Carcinoma Growth and Invasion Through Upregulation of TGF-alpha-, MSP- and HGF-mediated Signaling Networks Oncogene. Jul, 2005 | Pubmed ID: 15856015 Inhibition of VEGF-dependent Multistage Carcinogenesis by Soluble EphA Receptors Neoplasia (New York, N.Y.). Sep-Oct, 2003 | Pubmed ID: 14670182 Blockade of EphA Receptor Tyrosine Kinase Activation Inhibits Vascular Endothelial Cell Growth Factor-induced Angiogenesis Molecular Cancer Research : MCR. Nov, 2002 | Pubmed ID: 12496364 Soluble Eph A Receptors Inhibit Tumor Angiogenesis and Progression in Vivo Oncogene. Oct, 2002 | Pubmed ID: 12370823 The Ephrins and Eph Receptors in Angiogenesis Cytokine & Growth Factor Reviews. Feb, 2002 | Pubmed ID: 11750881 Bröst Transplantation av stromaceller och celler carcinoma in C57BL/6J Möss Nikki Cheng1, Diana L. Lambert1 1Department of Pathology, University of Kansas Medical Center JoVE 2716 Medicine
Bröst Transplantation av stromaceller och celler carcinoma in C57BL/6J Möss Nikki Cheng1, Diana L. Lambert1 1Department of Pathology, University of Kansas Medical Center JoVE 2716 Medicine